9,250 Shares in Humana Inc. $HUM Bought by Primecap Management Co. CA

Primecap Management Co. CA purchased a new stake in Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,250 shares of the insurance provider’s stock, valued at approximately $3,674,000.

Several other large investors have also bought and sold shares of HUM. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares during the last quarter. Sustainable Insight Capital Management LLC increased its position in shares of Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after acquiring an additional 4,740 shares during the last quarter. Manning & Napier Advisors LLC purchased a new stake in shares of Humana during the second quarter valued at approximately $1,412,000. Pzena Investment Management LLC bought a new stake in Humana during the second quarter worth $1,749,014,000. Finally, Swedbank AB lifted its holdings in Humana by 6.2% during the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after acquiring an additional 6,534 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on HUM. Robert W. Baird set a $390.00 price objective on Humana in a research note on Thursday, July 30th. TD Cowen lifted their target price on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research note on Friday, July 31st. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating on the stock. Raymond James Financial lowered shares of Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. Finally, Oppenheimer restated an “outperform” rating and set a $405.00 price objective on shares of Humana in a report on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $403.91.

Humana Stock Performance

NYSE:HUM opened at $390.06 on Thursday. The company has a market capitalization of $46.84 billion, a P/E ratio of 36.90, a P/E/G ratio of 2.22 and a beta of 0.72. The business has a fifty day simple moving average of $384.44 and a two-hundred day simple moving average of $286.38. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.27 EPS. On average, analysts expect that Humana Inc. will post 9.12 earnings per share for the current year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.